Q2 2020 Holdings
Filed 2020-07-24 | 2 holdings | $86.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Myovant Sciences Ltd. | COM | G637AM102 | $71.6K | 3,474,645 | 83.0% |
| Revance Therapeutics, Inc.(RVNCEUR) | COM | 761330109 | $14.6K | 598,985 | 17.0% |